Ignite Creation Date:
2025-12-26 @ 1:19 PM
Ignite Modification Date:
2025-12-29 @ 4:03 PM
Study NCT ID:
NCT05291806
Status:
COMPLETED
Last Update Posted:
2022-07-05
First Post:
2022-03-14
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Second Meal Effects of a Wholegrain Cereal Product on Blood Glucose Response
Sponsor:
Aventure AB
Organization:
Study Overview
Official Title:
Second Meal Effects of a Wholegrain Cereal Product on Blood Glucose Response
Status:
COMPLETED
Status Verified Date:
2022-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The aim of this study is to investigate second meal effects of a wholegrain cereal product on blood glucose response. The wholegrain cereal product will be consumed in the evening and blood glucose analyzed after a standardized breakfast meal the following morning.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: